PCSK9 and Hypercholesterolemia: Overexpression of miR-483 in mice liver increased hepatic LDL receptor levels by targeting PCSK9, leading to decreased plasma total cholesterol and LDL cholesterol levels, suggesting that microRNA-483 ameliorates hypercholesterolemia [34].